Navigate to
-
Designation demonstrates highest level of commitment to quality health care.
Prime Article: In the News -
Clinical Solutions VP (Remote) Looking for your next career move and want to help Prime Therapeutics (Prime) put more care in health care? Check out the Prime Careers Spotlight, a monthly roundup...
-
Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...
-
Integrated support for patients with cystic fibrosis drives down cost, improves medication adherence
Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate
PA Sub-Categories: Products Specialty drugs Prime Article: Stories -
Enhanced strategic consultation and new products like Medicare Predictive Model and Enrollment Capabilities are changing Prime’s government programs and delivering better access and costs to members
PA Sub-Categories: Products Technology Prime Article: Perspectives -
Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today
PA Sub-Categories: Corporate responsibility Prime Article: Perspectives -
A Q&A with Kristen Tveit, SVP, chief financial officer, Magellan Rx
PA Sub-Categories: Corporate responsibility Prime Article: Perspectives -
Tab 1 BEHAVIORAL HEALTH CORNER WEIGHT MANAGEMENT CORNER Clinical News EDITOR-IN-CHIEF: Maryam Tabatabai, PharmD EXECUTIVE EDITOR: Anna Schreck Bird, PharmD DEPUTY EDITORS: Erik Hamel, PharmD;...
-
AMCP Nexus offers opportunity to nurture next generation of managed care leaders
Prime Article: Stories -
Drug name/Manufacturer/Dosage form retatrutide/Eli Lilly/SC Drug name/Manufacturer/Dosage form semaglutide (Wegovy)/Novo Nordisk/SC tirzepatide (Zepbound)/Eli Lilly/SC T2DM Access the complete...
-
Live updates from AMCP Annual Meeting
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
The CDC is reporting influenza-like illness (ILI) for the week ending March 15, 2025 (week 11). Seasonal influenza activity remains increased across the U.S. but has decreased for five consecutive...
-
Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
The content in this publication is not a substitute for professional medical advice. For questions regarding any medical condition or if you need medical advice, please contact your health care...
-
AIS Health
Prime Article: In the News -
cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report -
Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics
Prime Article: Events -
Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...
Prime Article: Research & Publications PA Research & Publications: Prime Therapeutics Report -
Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of...
Prime Article: Stories -
Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service
PA Sub-Categories: GLP-1 Specialty drugs Technology Prime Article: Perspectives